Skip to Content
Download Image

UAB to participate in global clinical trial for coronavirus treatment

The University of Alabama at Birmingham announced that it will take part in an NIH-sponsored global clinical trial to evaluate the safety and efficacy of novel therapeutic agents in hospitalized adult patients diagnosed with COVID-19.

The drug remdesivir will be the first agent evaluated in the trial.

The UAB site was activated on Wednesday by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. That means it can begin enrollment as part of this phase three therapeutic clinical trial immediately.

Download Image

UAH lab joins supercomputing effort to find drugs against COVID-19

Stay connected to what's happening in Alabama now.

  • Enter your email address to receive periodic updates on the evolution of business in Alabama.

Ready to start your company's next chapter in Alabama?

Alabama may be small in size, but its ability to accommodate businesses seeking success is vast. See why companies like Mercedes, Airbus, Hyundai, and Honda have decided to call Alabama home.

Find A Site Learn More About Alabama